Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

24,446 total articles

Churchill Downs Incorporated Announces Update on Capital Projects at Churchill Downs Racetrack for 2027 and 2028

Churchill Downs Incorporated Announces Update on Capital Projects at Churchill Downs Racetrack for 2027 and 2028

Churchill Downs Incorporated (Nasdaq: CHDN) has provided an update on three major capital projects at its flagship racetrack, including construction of Victory Run, expansion of the Homestretch Club, and upgrades to Infield seating and amenities. These enhancements focus on premium hospitality experiences and are expected to be completed in time fo…

Beacon Financial Corporation Announces Second Quarter Results

Beacon Financial Corporation Announces Second Quarter Results

Beacon Financial Corporation announced robust second quarter 2026 earnings with net income rising to $64.4 million and EPS of $0.77, driven by improved operating momentum, merger integration progress, and disciplined execution. Total assets and deposits increased, net interest margin expanded, and expenses were reduced while maintaining credit disc…

Fortinet Reports Strong Second Quarter 2026 Financial Results

Fortinet Reports Strong Second Quarter 2026 Financial Results

Fortinet exceeded the high end of its Q2 2026 guidance with 26% year-over-year revenue growth to $2.05 billion and strong profitability metrics. The company raised its 2026 revenue guidance to 19% growth, driven by strong product and service revenue increases, robust billings growth, and continued innovation in AI-driven cybersecurity solutions. Fo…

MediaAlpha Announces Second Quarter 2026 Financial Results

MediaAlpha Announces Second Quarter 2026 Financial Results

MediaAlpha, Inc. announced strong second quarter 2026 financial results showing a 26% year-over-year revenue increase to $316.9 million, net income of $41.8 million compared to a prior year loss, and adjusted EBITDA growth. The company continued repurchasing stock and a portion of its tax receivables agreement liability, reflecting capital deployme…

Adamas Trust, Inc. Reports Second Quarter 2026 Results, Delivers Fourth Consecutive Quarter of Book Value Growth

Adamas Trust, Inc. Reports Second Quarter 2026 Results, Delivers Fourth Consecutive Quarter of Book Value Growth

Adamas Trust, Inc. announced robust second quarter 2026 financial results, marking its fourth consecutive quarter of book value growth. The company demonstrated a 36.4% year-over-year increase in earnings available for distribution per common share, achieving a book value per share of $10.16 and raising its quarterly dividend to $0.27 per share. Th…

Revolution Medicines to Report Financial Results for Second Quarter 2026 After Market Close on August 5, 2026

Revolution Medicines to Report Financial Results for Second Quarter 2026 After Market Close on August 5, 2026

Revolution Medicines, a late-stage clinical oncology company focused on targeted therapies for RAS-addicted cancers, will report its financial results for Q2 2026 on August 5, 2026, after market close. The company's senior management will host a webcast to discuss the results and provide an update on corporate progress. Several RAS(ON) inhibitors a…

Lifecore Biomedical to Report Financial Results for the Second Quarter Ended June 30, 2026, on August 5, 2026

Lifecore Biomedical to Report Financial Results for the Second Quarter Ended June 30, 2026, on August 5, 2026

Lifecore Biomedical, a Nasdaq-listed contract development and manufacturing organization specializing in sterile injectable pharmaceutical products, will report its financial results for Q2 ended June 30, 2026, on August 5, 2026, before market open. The company will host a webcast featuring senior management to discuss the financial outcomes.

DMC Global Reports Second Quarter Financial Results

DMC Global Reports Second Quarter Financial Results

DMC Global Inc. reported second quarter 2026 sales of $157 million, flat year over year and up 16% sequentially. Net income attributable to DMC was $0.5 million or $0.10 per diluted share. Adjusted EBITDA was $10.7 million, down 21% year over year but up 174% sequentially. Arcadia Products showed strong sales growth and improved profitability, whil…

Pool Corporation Declares Quarterly Cash Dividend

Pool Corporation Declares Quarterly Cash Dividend

Pool Corporation declared a quarterly cash dividend of $1.30 per share, payable on August 27, 2026, to shareholders of record on August 13, 2026. The company, a leading wholesale distributor of swimming pool and backyard products, operates extensively across North America, Europe, and Australia.

Teekay Corporation Ltd. Second Quarter 2026 Update

Teekay Corporation Ltd. Second Quarter 2026 Update

Teekay Corporation Ltd. reported an update for Q2 2026, highlighting its position as a leading provider of international crude oil marine transportation and marine services with its controlling stake in Teekay Tankers. The company manages a sizable fleet of mid-sized crude tankers and offers services including ship-to-ship transfers and contracts w…

Teladoc Health Reports Second Quarter 2026 Results

Teladoc Health Reports Second Quarter 2026 Results

Teladoc Health reported second quarter 2026 revenue of $606.9 million, down 4% year-over-year, with net loss of $38.9 million and adjusted EBITDA of $65.7 million. The Integrated Care segment showed 1% revenue growth and improved margin, while the BetterHelp segment revenue declined 12% amid shifting consumer payment preferences towards insurance. …

Tenable Announces Second Quarter 2026 Financial Results

Tenable Announces Second Quarter 2026 Financial Results

Tenable Holdings, Inc. announced its second quarter 2026 financial results, highlighting an 8.6% year-over-year revenue increase to $268.5 million and significant improvements in profitability metrics. The company showcased strong operational performance with GAAP operating margin rising to 4.6% from a loss in the prior year, and non-GAAP operating…

Amplify Energy to Participate in the 2026 EnerCom Denver

Amplify Energy to Participate in the 2026 EnerCom Denver

Amplify Energy Corp. will participate in the 31st Annual EnerCom Denver Energy Investment Conference, with CEO Dan Furbee conducting investor meetings and delivering a presentation on August 18, 2026. The event offers an opportunity for the company to engage with investors and share updates about its oil production operations focused in the Pacific…

Robinhood Reports Second Quarter 2026 Results

Robinhood Reports Second Quarter 2026 Results

Robinhood Markets, Inc. announced strong second quarter 2026 results with revenues up 32% year-over-year to $1.31 billion and diluted EPS rising 48% to $0.62. The company saw record net deposits of $22 billion and reached 4.8 million Robinhood Gold subscribers. Diversification continues with 13 business lines generating over $100 million in annuali…

Climb Global Solutions Reports Second Quarter 2026 Results

Climb Global Solutions Reports Second Quarter 2026 Results

Climb Global Solutions announced its second quarter 2026 financial results, showing a 9% increase in net sales to $174.2 million and a 17% rise in gross billings to $587.3 million, driven by organic growth and the recent acquisition of Interworks.cloud. Despite higher revenues, net income slightly declined to $5.5 million due to increased expenses,…

60 Degrees Pharmaceuticals Announces Minimum Enrollment Achieved in Hospitalized Babesiosis Study; Interim Data Readout Planned by October 6, 2026

60 Degrees Pharmaceuticals Announces Minimum Enrollment Achieved in Hospitalized Babesiosis Study; Interim Data Readout Planned by October 6, 2026

60 Degrees Pharmaceuticals has enrolled the minimum 24 patients required to trigger an interim analysis in its Phase 2 clinical study evaluating tafenoquine plus standard of care versus placebo for severe babesiosis treatment. The interim data is expected by October 6, 2026, after which the company plans to meet with the FDA to discuss regulatory p…